Head-to-Head

Aktis Oncology, Inc. Common stock vs. Eli Lilly & Co.

AKTS

Aktis Oncology, Inc. Common stock

$16.55 -0.45%

VS LLY

Eli Lilly & Co.

$1456.39 +0.89%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AKTSLLY
Market Cap $927.36 million $1.29 trillion

LLY leads on 1 of 1 size & scale factors.

Dividend

AKTSLLY
Dividend Yield — 0.48%

AKTS and LLY split the dividend factors evenly.

Risk & Sentiment

AKTSLLY
Short Interest 1.61% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: AKTS overview, AKTS financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.